Pricing Log in Create free account

Bionano Genomics, Inc. (BNGO) vs Femasys Inc. (FEMY)

Bionano Genomics, Inc. and Femasys Inc. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. is the larger, with a market value of $15.4M against $11.0M — 1.4× the size. Femasys Inc. grew revenue faster over the last twelve months: 21.9% against 10.0%. Bionano Genomics, Inc. has the higher net margin (−106.6% vs −534.3%) and the higher return on invested capital (−81.7% vs −176.9%). Across the 18 metrics below, Bionano Genomics, Inc. leads on 15 and Femasys Inc. on 3.

Valuation

Metric BNGO FEMY Medical Instruments & Supplies median
P/E n/m n/m 30.28
P/S 0.42 1.93 2.49
P/B 0.41 1.10 2.34
Price to free cash flow n/m n/m 23.49
EV/EBITDA n/m n/m 14.87
EV/Sales 0.67 2.87 2.75
Earnings yield (338.71%) (347.05%) 0.00%
Free cash flow yield (160.60%) (407.89%) 0.59%

Profitability

Metric BNGO FEMY Medical Instruments & Supplies median
Gross margin 47.51% 60.95% 53.60%
Operating margin (106.67%) (763.90%) 1.97%
Net margin (106.58%) (534.27%) 0.00%
Free cash flow margin (67.87%) (786.02%) 2.36%
Return on equity (83.56%) (443.65%) 0.00%
Return on assets (52.04%) (94.25%) 0.00%
Return on invested capital (81.68%) (176.91%) 0.13%

Growth

Metric BNGO FEMY Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% 21.85% 8.97%
EPS growth (last fiscal year) 94.50% 44.71% 6.51%
Revenue growth, 5-year CAGR 27.37% 17.18% 8.85%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNGO FEMY Medical Instruments & Supplies median
Debt to equity 0.11 0.90 0.10
Current ratio 2.48 2.14 2.47
Net debt to EBITDA 1.06 0.23 0.97

Dividend

Metric BNGO FEMY Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric BNGO FEMY Medical Instruments & Supplies median
Market cap 15.37m 10.97m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack